Halving duration of ADT for high risk prostate cancer patients

Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery

Pooled analysis of avelumab for metastatic urothelial carcinoma

Delaying metastatic prostate cancer, improving survival with abiraterone

STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression/deaths

Hypogonadism following cisplatin treatment of testicular cancer

Low testosterone after testicular cancer could be linked to chronic health problems

Editor's Choice for April 2017

Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030

Glycemia positively associated with prostate cancer mortality in non-diabetic men

Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Editor's Choice for January 2017